vs
Side-by-side financial comparison of Citizens Financial Group (CFG) and Kenvue (KVUE). Click either name above to swap in a different company.
Kenvue is the larger business by last-quarter revenue ($3.9B vs $2.2B, roughly 1.8× Citizens Financial Group). Citizens Financial Group runs the higher net margin — 23.8% vs 12.1%, a 11.7% gap on every dollar of revenue. On growth, Citizens Financial Group posted the faster year-over-year revenue change (12.0% vs 4.5%). Over the past eight quarters, Citizens Financial Group's revenue compounded faster (5.1% CAGR vs -1.1%).
Citizens Financial Group, Inc. is an American bank holding company, headquartered in Providence, Rhode Island. The company owns the bank Citizens Bank, N.A., which operates in the U.S. states of Connecticut, Delaware, Florida, Maryland, Massachusetts, Michigan, New Hampshire, New Jersey, New York, Ohio, Pennsylvania, Rhode Island, Vermont, and Virginia, as well as Washington, DC.
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue owns well-known brands such as Aveeno, Band-Aid, Benadryl, Combantrin, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine. Kenvue is incorporated in Delaware and was originally headquartered in the Skillman section of Montgomery Township, New Jersey, before relocating to Summit, New Jersey.
CFG vs KVUE — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2027
| Metric | | |
|---|---|---|
| Revenue | $2.2B | $3.9B |
| Net Profit | $517.0M | $474.0M |
| Gross Margin | — | 58.9% |
| Operating Margin | — | 19.6% |
| Net Margin | 23.8% | 12.1% |
| Revenue YoY | 12.0% | 4.5% |
| Net Profit YoY | 38.6% | 47.2% |
| EPS (diluted) | $1.13 | $0.25 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $2.2B | $3.9B | ||
| Q4 25 | $2.2B | $3.8B | ||
| Q3 25 | $2.1B | $3.8B | ||
| Q2 25 | $2.0B | $3.8B | ||
| Q1 25 | $1.9B | $3.7B | ||
| Q4 24 | $2.0B | $3.7B | ||
| Q3 24 | $1.9B | $3.9B | ||
| Q2 24 | $2.0B | $4.0B |
| Q1 26 | $517.0M | $474.0M | ||
| Q4 25 | $528.0M | $330.0M | ||
| Q3 25 | $494.0M | $398.0M | ||
| Q2 25 | $436.0M | $420.0M | ||
| Q1 25 | $373.0M | $322.0M | ||
| Q4 24 | $401.0M | $293.0M | ||
| Q3 24 | $382.0M | $383.0M | ||
| Q2 24 | $392.0M | $58.0M |
| Q1 26 | — | 58.9% | ||
| Q4 25 | — | 56.5% | ||
| Q3 25 | — | 59.1% | ||
| Q2 25 | — | 58.9% | ||
| Q1 25 | — | 58.0% | ||
| Q4 24 | — | 56.5% | ||
| Q3 24 | — | 58.5% | ||
| Q2 24 | — | 59.1% |
| Q1 26 | — | 19.6% | ||
| Q4 25 | 31.4% | 14.2% | ||
| Q3 25 | 29.7% | 16.7% | ||
| Q2 25 | 27.2% | 18.0% | ||
| Q1 25 | 24.2% | 14.9% | ||
| Q4 24 | 25.6% | 13.2% | ||
| Q3 24 | 24.7% | 16.8% | ||
| Q2 24 | 24.5% | 3.9% |
| Q1 26 | 23.8% | 12.1% | ||
| Q4 25 | 24.5% | 8.7% | ||
| Q3 25 | 23.3% | 10.6% | ||
| Q2 25 | 21.4% | 10.9% | ||
| Q1 25 | 19.3% | 8.6% | ||
| Q4 24 | 20.2% | 8.0% | ||
| Q3 24 | 20.1% | 9.8% | ||
| Q2 24 | 20.0% | 1.5% |
| Q1 26 | $1.13 | $0.25 | ||
| Q4 25 | $1.12 | $0.16 | ||
| Q3 25 | $1.05 | $0.21 | ||
| Q2 25 | $0.92 | $0.22 | ||
| Q1 25 | $0.77 | $0.17 | ||
| Q4 24 | $0.83 | $0.16 | ||
| Q3 24 | $0.77 | $0.20 | ||
| Q2 24 | $0.78 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $1.1B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $26.2B | — |
| Total Assets | $227.9B | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $1.1B | ||
| Q4 25 | — | $1.1B | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.0B |
| Q1 26 | — | — | ||
| Q4 25 | $11.2B | — | ||
| Q3 25 | $10.4B | — | ||
| Q2 25 | $12.5B | — | ||
| Q1 25 | $12.3B | — | ||
| Q4 24 | $12.4B | — | ||
| Q3 24 | $13.9B | — | ||
| Q2 24 | $13.1B | — |
| Q1 26 | $26.2B | — | ||
| Q4 25 | $26.3B | $10.8B | ||
| Q3 25 | $25.8B | $10.6B | ||
| Q2 25 | $25.2B | $10.7B | ||
| Q1 25 | $24.9B | $10.1B | ||
| Q4 24 | $24.3B | $9.7B | ||
| Q3 24 | $24.9B | $10.6B | ||
| Q2 24 | $23.9B | $10.2B |
| Q1 26 | $227.9B | — | ||
| Q4 25 | $226.4B | $27.1B | ||
| Q3 25 | $222.7B | $27.2B | ||
| Q2 25 | $218.3B | $27.1B | ||
| Q1 25 | $220.1B | $26.3B | ||
| Q4 24 | $217.5B | $25.6B | ||
| Q3 24 | $219.7B | $26.9B | ||
| Q2 24 | $219.9B | $26.4B |
| Q1 26 | — | — | ||
| Q4 25 | 0.43× | — | ||
| Q3 25 | 0.40× | — | ||
| Q2 25 | 0.50× | — | ||
| Q1 25 | 0.49× | — | ||
| Q4 24 | 0.51× | — | ||
| Q3 24 | 0.56× | — | ||
| Q2 24 | 0.55× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
